GSK Servicessp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2005-04-07
Share capital
258 050 000,00 PLN
Registered address
Grunwaldzka 189, 60-322 Poznań, Poland
Electronic delivery address
AE:PL-15474-38006-FUBGG-17

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 680.16mMedianUSD 873.84kAverageUSD 20.03m
Net profit
This companyUSD 15.14mMedianUSD 28.21kAverageUSD 815.54k
Operating costs
This companyUSD 644.60mMedianUSD 801.08kAverageUSD 18.78m
Assets
This companyUSD 379.85mMedianUSD 539.29kAverageUSD 10.66m

Industry

Bank accounts

Registered as a VAT taxpayer on 2005-12-30. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication dateEvent
Sep 15, 2022Creditor repayment plan

Public aid

No public aid cases recorded in the last 10 years.

Tenders

731 tenders recorded as contractor: 180 national ($5,631,278) and 551 EU ($6,273,688,701).

Publication dateSubjectAmountContracting authority
Oct 2, 2026
Dostawa leków do chemioterapii i programów lekowych 2026-2028
—Wojewódzki Szpital Specjalistyczny We Wrocławiu
Oct 2, 2026
Dostawa leków programowych, onkologicznych, płynów infuzyjnych, erytropoetyny oraz kontrastów
—Wojewódzki Szpital Specjalistyczny Nr 4 w Bytomiu
Oct 1, 2026
Dostawy produktów farmaceutycznych
—Samodzielny Publiczny Zespół Opieki Zdrowotnej w Świdnicy

Regulatory authorisations

AuthorityTypeStatus
BDO register entry
BDO
Active

Authorized Representatives

Anita Arndt Czaplicka — Management Board Member
Anna Maria Tempińska — Attorney-in-fact (sole)
Gabriel Catalán Sagredo — Management Board Member
Małgorzata Halina Lasota — Management Board Member
Joanna Jadwiga Watras — Management Board Member

Manner of representation

For representing the company externally, making declarations of will and signing on behalf of the company, in the case of a one-person management board, the President of the Management Board is authorized to act individually, and in the case of a multi-member management board, the President of the Management Board jointly with a member of the management board, two members of the management board jointly, the President of the Management Board jointly with a commercial proxy, or a member of the management board jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
GSK Psc Poland sp. z o.o.
516,100$69,705,564.56100%

Beneficial owners

9 beneficial owners recorded in CRBR.

PersonRights
Anita Katarzyna Arndt-Czaplicka (57)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).
Julie Belita Brown (64)
Natural person holding a senior management position in a parent entity (e.g. parent company).
Gabriel Eduardo Catalan Sagredo (37)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).
Krzysztof Tomasz Kępiński (49)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).
Małgorzata Halina Lasota (49)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).
Marcin Osiecki (43)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).
Zuzana Remrova (48)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).
Wojciech Maciej Skrudlik (50)
Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).

Competitors

Name
Fresenius Medical Care PolskaS.A.
Revenue: $81,891,916.01 · freseniusmedicalcare.pl
Dermaticsp. z o.o.
Revenue: $33,423,317.64 · dermatic.pl
EMS - Euromed Medical Solutionsp. z o.o.
Revenue: $14,713,557.54 · euromed.net.pl
MedaseptS.A.
Revenue: $8,612,031.18 · medasept.pl
PHS Hospitalsp. z o.o. + limited partnership
Revenue: $1,933,301.24 · phs.med.pl
Medaidsp. z o.o.
Revenue: $1,034,514.88 · medaid.pl
Medicallenssp. z o.o.
Revenue: $179,960.83 · medicallens.com
Integris Medical Polskasp. z o.o.
Revenue: $159,033.76 · integrismedical.pl
Aptekssp. z o.o.
Revenue: $13,537.42 · apteks.com
HA Technologiessp. z o.o.
Revenue: $206.67 · amalian.pl

Change history

DateEvent
2021-09-29Share capital change (191,050,000.00 PLN → 258,050,000.00 PLN)
2021-09-29PKD change (Removed: 62.03.Z)
2016-01-20PKD change (Removed: 17.23.Z, 18.11.Z, 18.12.Z, 18.20.Z, 46.38.Z, 46.45.Z, 47.29.Z, 47.73.Z, 47.74.Z, 47.75.Z, 58.11.Z, 58.12.Z, 58.13.Z, 58.14.Z, 58.19.Z, 58.29.Z, 59.11.Z, 59.12.Z, 59.13.Z, 59.20.Z, 60.10.Z, 60.20.Z, 63.12.Z, 63.99.Z, 72.19.Z, 73.11.Z, 73.20.Z, 74.10.Z, 74.20.Z, 74.30.Z, 74.90.Z, 77.11.Z, 77.12.Z, 77.40.Z, 82.11.Z, 82.19.Z, 82.91.Z, 82.92.Z, 82.99.Z, 85.32.A, 85.59.B, 86.90.E)
2010-10-21PKD change (Removed: 22.1, 22.2, 22.3, 51.38.B, 51.45.Z, 51.46.Z, 52.27.B, 52.3, 72.10.Z, 72.21.Z, 72.30.Z, 72.40.Z, 72.60.Z, 73.10.D, 73.10.F, 74.11.Z, 74.12.Z, 74.13.Z, 74.14.A, 74.40.Z, 74.81.Z, 74.82.Z, 74.85.Z, 74.87.B, 80.42.B, 85.1, 92.11.Z, 92.12.Z; Added: 17.23.Z, 18.11.Z, 18.12.Z, 18.20.Z, 46.38.Z, 46.45.Z, 46.46.Z, 47.29.Z, 47.73.Z, 47.74.Z, 47.75.Z, 58.11.Z, 58.12.Z, 58.13.Z, 58.14.Z, 58.19.Z, 58.21.Z, 58.29.Z, 59.11.Z, 59.12.Z, 59.13.Z, 59.20.Z, 60.10.Z, 60.20.Z, 62.01.Z, 62.02.Z, 62.03.Z, 62.09.Z, 63.11.Z, 63.12.Z, 63.99.Z, 69.10.Z, 69.20.Z, 70.21.Z, 70.22.Z, 72.19.Z, 73.11.Z, 73.20.Z, 74.10.Z, 74.20.Z, 74.30.Z, 74.90.Z, 77.11.Z, 77.12.Z, 77.40.Z, 82.11.Z, 82.19.Z, 82.91.Z, 82.92.Z, 82.99.Z, 85.32.A, 85.59.B, 86.90.E)
2006-02-27Share capital change (50,000.00 PLN → 191,050,000.00 PLN)

FAQ

Last updated: 2026-07-15